ISRCTN51902376已完成不适用
Taurolidine-citrate catheter locks for the prevention of bacteraemia in patients using tunnelled intravascular catheters for haemodialysis: a randomised double-blind controlled trial
ancashire Teaching Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 100 人开始时间: 2009年9月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult patients (aged greater than 18 years), either sex
- •2. Requirement for dialysis using a tunnelled dialysis line
- •3. Able to give informed consent
排除标准
- •1. Children aged less than 18 years
- •2. Unable to give informed consent
- •3. Positive blood culture in previous seven days
- •4. Unstable bleeding diathesis or hypercoagulable state
研究者
相似试验
尚未招募
不适用
Taurolidine 2% catheter locking to prevent catheter-related bloodstream infections in patients on home parenteral nutrition with a high infection risk and those with a new central venous access device: A double-blind multicenter randomized controlled trial under guidance of the Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEintestinal failure, home parenteral nutritioncatheter-related bloodstream infections (CRBSI)10004018NL-OMON36907niversitair Medisch Centrum Sint Radboud20
已完成
4 期
Taurolidine Lock in Long Term Parenteral NutritionHome Parenteral NutritionCentral Venous CatheterNCT02009189Stanley Dudrick's Memorial Hospital30
已完成
不适用
Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patientsCatheter-related infectionsInfections and InfestationsISRCTN86885538Tauropharm (Germany)100
已完成
不适用
Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%Catheter Related Blood Stream InfectionsNCT01826526Geert Wanten105
已完成
不适用
Prevention of Catheter Lumen Occlusion with recombinant tissue plasminogen activator (rT-PA) versus Heparin (Pre-CLOT): A Double Blind Randomized TrialKidney diseaseISRCTN35253449niversity of Calgary (Canada)340